Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Maintains Market Perform on Myriad Genetics, Raises Price Target to $30

SVB Leerink Maintains Market Perform on Myriad Genetics, Raises Price Target to $30

SVB Leerink analyst Puneet Souda maintains Myriad Genetics (NASDAQ:MYGN) with a Market Perform and raises the price target from $26 to $30.

August 5, 2022

1 minute read

SVB Leerink analyst Puneet Souda maintains Myriad Genetics (NASDAQ:MYGN) with a Market Perform and raises the price target from $26 to $30.

‘VP Services Peter Stern To Leave The Company’ – Insider

January 9, 2:55 PM

https://www.businessinsider.com/apple-subscriptions-top-exec-peter-stern-leaving-company-services-2023-1

June 13, 8:16 AM

Shares of Broadcom Inc. (NASDAQ:AVGO) rose sharply in today’s pre-market trading after the company posted stronger-than-expected results for…

April 4, 10:00 AM

Analysts have provided the following ratings for Corebridge Financial (NYSE:CRBG) within the last quarter: Bullish Somewhat Bullish Indifferent…

December 12, 9:00 AM

A 10-minute phone call has resulted in a user's Pixel 6 Pro overheating, resulting in the Tensor-powered phone giving up the ghost.